Review Article
Endoscopic Treatment of Vesicoureteral Reflux with Dextranomer/Hyaluronic Acid in Children
Table 3
Variables affecting the outcome of endoscopic treatment of VUR with Deflux.
Overall success for patients/ureters.
| Reference | Bulking agent | Patients/Ureters | Mean age | Overall success | Predictors of success | Not predictive |
| Lavelle et al. 2005 [40] | Dx/HA | 52/80 | 7.6 years | 71%/80% | Volcano: present 87% | Voiding dysfunction | | | | | | absent 53% | VUR grade | | | | | | | Injected volume | Yucel et al. 2007 [41] | Dx/HA | 168/259 | 4.2 years | 82%/86% | Volcano: present 87% | Voiding dysfunction | | | | | | absent 36% | Laterality | | | | | | Volume: <0.5 mL success | | | | | | | >0.5 mL failure | | | | | | | VUR grade | | Routh et al. 2007 [42] | Dx/HA | 301/453 | 5.5 years | 66%/72% | VUR grade | | | | | | | Surgeon | |
|
|